Bronchoscopic Management of Tracheobronchial Stenosis Secondary to Granulomatosis with Polyangitis
Introduction Granulomatosis with Polyangitis (GPA), previously known as Wegener’s Granulomatosis, is a form of anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis predominantly involving the upper and lower respiratory tract and kidneys. Tracheobronchial involvement in GPA can have varied manifestations which include airway inflammation, mucosal granulomas, tracheobronchial stenosis, tracheal and endobronchial mass lesions (inflammatory pseudotumors), tracheobronchomalacia and tracheoesophageal fistulae. Tracheobronchial involvement is seen in nearly 30 to 50% of the cases. The subglottic portion of the trachea is most commonly affected. Management of tracheobronchial GPA is complex, including endoscopic and surgical approach. The management of lower tracheal and bronchial stenosis is less reported than subglottic stenosis in tracheobronchial GPA.
Case Report A 57-year-old gentleman was previously diagnosed to have granulomatosis with polyangitis (GPA) since 2015. At diagnosis, he presented with right orbital cellulitis with peripheral ulcerative keratitis, left maxillary sinusitis and diffuse alveolar hemorrhage. He underwent right enucleation and the histopathology of the right eye globe showed focal fibrinoid necrosis of small blood vessels with multinucleated giant cells suspicious of vasculitis. He also underwent functional endoscopic sinus surgery (FESS) and the histopathology of the right nasal septal biopsy was consistent with necrotizing granulomatous inflammation. No causative pathogens were identified by cultures and histopathology. He had tested positive for PR3 antibodies and C-ANCA. He received tracheostomy due to prolonged intubation. He was successfully treated with plasmapheresis, pulse methylprednisolone and 10 cycles of intravenous cyclophosphamide pulse therapy. He was on maintenance treatment with azathioprine 50 mg/day and prednisolone 20 mg/day. After discharge, he had a productive cough and occasional noisy breathing. He had dyspnea on exertion and could climb a flight of stairs. For this admission, he presented to the department of otorhinolaryngology with worsening dyspnea for 1 week with difficulty in expectoration. He had no fever.
Physical examination revealed severe respiratory distress and paradoxical breathing with stridor and generalized rhonchi on both lungs. His chest X-ray showed no infiltrate. Complete blood count showed mild elevation of white blood cell count with neutrophil predominance. After initiation of mechanical ventilation, his symptoms were improved but he still had inspiratory rhonchi in both lungs. Flexible bronchoscopy was performed to evaluate the central airway. Bronchoscopic findings included subglottic stenosis with small granulation tissue above the stoma of tracheostomy and diffuse mucosal inflammation of tracheobronchial trees. Mid to lower trachea were 70% stenosis due to mucosal swelling and tracheomalacia. Left main bronchus and segmental bronchi showed 60% collapse during expiration due to bronchomalacia.
Treatment Rigid bronchoscopy was done under general anesthesia. Tracheal dilatation was performed by using balloon dilatation and rigid bronchoscope. Left main bronchus was also dilated using balloon dilatation. A silicone stent was then placed in the lower trachea. The proximal end of the stent was just below the tip of the tracheostomy tube and the distal end of the stent was above the carina.
Discussion Granulomatosis with Polyangitis is a necrotizing granulomatous inflammation mainly involving the upper and lower respiratory tract. Immunosuppressive therapy remains the mainstay of treatment in patients with GPA. Tracheobronchial involvement often runs a course independent of other manifestations of GPA, and effective local treatment of airway lesions can lead to an early tapering of systemic immunosuppression in selected patients. A spectrum of patients continues to develop symptoms of airway obstruction despite clinical remission induced by standard immunosuppressive regimens as evident in our case where remission induction was successful. Prompt recognition and airway management can lead to the reduction in pulmonary morbidity and to prevent life-threatening ventilatory and infective complications. Tracheobronchial stenosis may not always respond to systemic immunosuppressive therapy. The symptoms and overall general condition of a patient and the severity of the stenosis should determine the appropriate treatment strategy on an individualized basis.Therapeutic alternatives to standard medical therapy include resection and reconstructive surgery, tracheostomy, and endoscopic approach. Various endoscopic methods have been described in the literature, but there is no consensus statement on the optimal therapeutic approach. The different endoscopic techniques have been described including balloon dilatation, intralesional steroid injection, laser resection, endoluminal spray cryotherapy and stent placement.There is a divergence of opinion regarding the optimal endoscopic approach in patients with tracheobronchial GPA. Though surgical reconstruction remains the standard of care, it is not always feasible for the surgeon to resect and reconstruct, especially when the disease is not localized, as in our case where there is multilevel obstruction. Endoscopic dilatation is a minimally invasive procedure causing least insult to the airway epithelium and can be accomplished by serial rigid tube dilatation or balloon catheter. Some authors have shown that dilatation combined with intralesional corticosteroid injection, especially in cases of active tracheobronchial GPA would obviate the need for airway bypass surgery or stenting while preventing the long-term complication of chronic airway scarring. Nouraei and colleagues have reported that the requirement for tracheostomy could be reduced from 40-50% to zero. But this is not always possible, especially when the patients present acutely with life-threatening obstruction. The use of airway stents to maintain airway patency in tracheobronchial GPA is also largely debated. Silicone stents are preferred because metal stents can be removed with great difficulty and may also penetrate to the adjacent tissue. In our case, we used a silicone stent to maintain patency of the lower trachea after serial tracheal dilatation using balloon and rigid bronchoscope. Though there is a lot of controversies regarding the use of airway stents in tracheobronchial GPA, our case report demonstrates that silicone stent placement provides symptomatic relief and should be considered when other conservative methods fail to restore airway patency. Daum and colleagues observed that silicone stents provided persistent airway patency when compared to rigid tube dilatation and YAG laser therapy. In this case, bronchoscopic balloon dilatation and stent placement led to significant clinical improvement, and we were able to wean the patient off the ventilator immediately following the procedure. Surveillance bronchoscopy one month later showed good luminal patency with very minimal secretions.
Keywords Polyangitis; Tracheostomy; Critical airway
Author : Happidoc Content Team